---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-002664"
form_type: "8-K"
ticker: "PLSE"
cik: "0001625101"
company_name: "PULSE BIOSCIENCES, INC."
filed_at: "2025-02-04T23:59:59+00:00"
generated_at: "2026-05-27T03:30:02.074470+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Pulse Biosciences appoints Jon Skinner as CFO effective Feb 3, 2025

## Summary
- Jon Skinner appointed CFO effective Feb 3, 2025; previously VP at Copeland and Imperative Care.
- Annual base salary $400,000, target bonus 50% of salary, sign-on bonus up to $56,000.
- Granted option for 300,000 shares at $20.93 (closing on Jan 31, 2025) with four-year vesting.
- Half of options vest time-based over 4 years; half vest based on market cap and revenue milestones.
- Milestones include market caps of $2B to $5B and GAAP product revenues of $8M to $175M.

## SEC filing metadata
- accession: 0001437749-25-002664
- form_type: 8-K
- ticker: PLSE
- cik: 0001625101
- company_name: PULSE BIOSCIENCES, INC.
- filed_at: 2025-02-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625101/000143774925002664/0001437749-25-002664-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625101/000143774925002664/plse20250131_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-002664
- JSON: https://secwatch.observer/filing/0001437749-25-002664.json
- Plain text: https://secwatch.observer/filing/0001437749-25-002664.txt

## Key facts
- Executive change
  Jon Skinner was appointed as Chief Financial Officer at PULSE BIOSCIENCES, INC..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: Pulse Biosciences, Inc. (the “Company”) has appointed Jon Skinner as Chief Financial Officer of the Company, effective as of February 3, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/1625101/000143774925002664/0001437749-25-002664-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.